[Standard-dose of idarubicin in combination with continuous infusion of cytarabine as induction therapy in patients with acute myeloid leukaemia].

Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology

Volumn 17, Issue 1, 2009, Pages 209-213

  Qian, Si Xuan ^a   Li, Jian Yong ^b   Wu, Han Xin ^b   Lu, Hua ^b   Qiu, Hong Xia ^b   Chen, Li Juan ^b   Lu, Rui Nan ^b   Xu, Wei ^b   Sheng, Rui Lan ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; FEMALE; HUMANS; IDARUBICIN; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955937157     PISSN: 10092137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)